Yüklüyor......
Continuous dose-intense temozolomide and cisplatin in recurrent glioblastoma patients
In glioblastoma multiforme (GBM), both temozolomide (TMZ) and cisplatin are very active at various toxic levels. Previous studies demonstrated that cisplatin with the standard regimen of TMZ is active in patients suffering from recurrent GBM, generating a moderate level of toxicity. Also, continuous...
Kaydedildi:
| Yayımlandı: | Medicine (Baltimore) |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wolters Kluwer Health
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5348180/ https://ncbi.nlm.nih.gov/pubmed/28272232 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000006261 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|